Skip to main content Skip to main navigation menu Skip to site footer
International Journal of Nutrology
Case Report
DOI: 10.1055/s-0040-1705647
Submitted: 02-14-2022
Published: 02-14-2022

A importância da microbiota no organismo humano e sua relação com a obesidade

Médica Cardiologista, São José do Rio Preto - SP, Brasil
Intestinal microbiota obesity overweight energetic metabolism immunity

Abstract

This paper is a bibliographic review aiming to describe the importance of microbiota in the human organism and its relationship with obesity. Original scientific articles and reviews from indexed journals such as Brazilian Cardiology articles, Scielo PubMed/Medline, SeCs were compiled. The present work described that microbiota is a population of microscopic organisms that live into the human body. Intestinal microbiota influences gastrointestinal diseases and a great variety of immunological conditions such as, diabetes mellitus type I, cardiovascular diseases, autoimmune demyelinating diseases, allergy, asthma and obesity. There is a close association between intestinal microbiota and body weight due to a modification in bacterial composition of obese people which is different from those with normal BMI. The increase in the number of health promoting microorganisms in the gastrointestinal tract may be achieved by eating prebiotic and probiotic food. They change microbiota composition by creating a barrier against bad bacteria from the ecosystem. Such paper has demonstrated that when preserving intestinal integrity, it is possible to avoid the occurrence of diseases by preventing the entrance of pathogenic and antigenic microorganisms.

Metrics

Metrics Loading ...

References

  1. THOMAS DW, GREER FR. American Academy of Pediatrics Commitee on Nutrition: American Academy of Pediatrics Section on Gastroentterology, Hepatology, and Nutrition. Probiotics and prebiotcs in pediatrics. Pediatrics 2010; 126:1217-31.
  2. BEDANI, R.; ROSSI, E. A. Microbiota Intestinal e probióticos: implicações sobre o câncer de cólon. Jornal Português de Gastrenterologia. v. 16, n. 1, p. 19-28. 2009.
  3. DIBAISE, J.K. et al. Gut Microbiota and Its Possible Relationship with Obesity. Mayo Clinic Proceedings, Oxford, v.83, no.4, p.460-469, 2008.
  4. FANDIÑO, J.; e colaboradores. Cirurgia Bariátrica: aspectos clínico-cirúrgicos e psiquiátricos. Rev de Psiq RS. Vol. 26. Num. 1. jan/abr. 2004. p. 47-51.
  5. FAO; WHO. Health and Nutritional Properties of Profiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Argentina, out. 2001.
  6. BOURLIOUX, P.; KOLETZKO, B.; GUARNER, F.; BRAESCO, V. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium “The Intelligent Intestine,” held in Paris. American Journal of Clinical Nutrition, v. 78, n. 4, p. 675-683. 2003.
  7. WU GD & LEWIS JD (2013). Analysis of the human gut microbiome and association with disease. Clinical Gastroenterology Hepatology 11(7):774-777.
  8. ARUMUGAM M, RAES J, PELLETIER E, Le PASLIER D, YAMADA T, MENDE DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-80.
  9. QIN J, Li R, RAES J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65.
  10. TREMAROLI V & BÄCKHED F (2012). Functional interactions between the gut microbiota and host metabolism. Nature 489:242-249.
  11. ROBLES Alonso V & Guarner F (2013). Linking the gut microbiota to human health. British Journal of Nutrition 109:S21-S26.
  12. ADLERBERTH I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr.2009;98(2):229–238.
  13. TSUKUMO Daniela M., CARVALHO Bruno M., CARVALHO-Filho Marco A., Saad Mário J. A.. Translational research into gut microbiota: new horizons in obesity treatment. Arq Bras Endocrinol Metab [Internet]. 2013 Dez [citado 2016 Jun 22] ; 57( 9 ): 753-753.
  14. ALMEIDA, L. B.; MARINHO, C. B.; SOUZA, C. S.; CHEIB, V. B. P. Disbiose intestinal. Revista Brasileira de Nutrição Clínica. v. 24, n. 1, p. 58-65. 2009.
  15. VARAVALLO, M. A.; THOMÉ, J. N.; TESHIMA, E. Aplicação de bactérias probióticas para profilaxia e tratamento de doenças gastrointestinais. Semina: Ciências Biológicas e da Saúde. v. 29, n. 1, p. 83-104. 2008.
  16. BÄCKHED F, FRASER CM, RINGEL Y, et al. (2012). Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 12(5):611-622.
  17. GAO Z, TSENG CH, PEI Z et al. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci USA 2007; 104:2927–32.
  18. SILVA, L.P.; NÖRNBERG, J.L. Prebióticos na nutrição de não-ruminantes.Ciência Rural, v.33, n.4, p.55-65, 2003.
  19. CONTERNO, L. et al. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr., v. 6, p. 241-260, 2011.
  20. MUSSO, G., GAMBINO, R.; CASSADER, M. Interactions between gut microbiota and host metabolismo predisposing to obesity and diabetes. Annu. Rev. Med., v.63, p. 361-380, 2011.
  21. BÄCKHED F, DING H, WANG T, HOOPER LV, KOH GY, NAGY A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101(44):15718-23.
  22. BERNHARD, F. et al. Functional relevance of genes implicated by obesity genome-wide association study signals for human adipocyte biology. Diabetologia. Berlin, v. 56, p. 311-322, 2013.
  23. SARTOR, R.B. — Microbial influences in inflammatory bowel disease. Gastroenterology, 134: 577-94, 2008.
  24. FAVA F, GITAU R, GRIFFIN BA, et al. (2013). The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. International Journal of Obesity 37(2):216-223.
  25. CLARKE SF, MURPHY EF, NILAWEERA K, et al. (2012). The gut microbiota and its relationship to diet and obesity. Gut Microbes 3(3):186-202.
  26. MOLINARO, PASCHETTA E, CASSADER M, et al. (2012). Probiotics, prebiotics, energy balance, and obesity – mechanistic insights and therapeutic implications. Gastroenterology Clinics of North America 41(4):843-854.
  27. LEY RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022-3.; 24.
  28. LEY RE, BÄCKHED F, TURNBAUGH P, LOZUPONE CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 2005;102(31):11070-5.
  29. VANDENPLAS Y, VEEREMAN-WAUTERS G, DEGREEF E, et al. Probiotcs and prebiotics in prevention and treatment of diseases in infants and children. J Pediatr (Rio J) 2011; 87(4):292-300.
  30. KOSIEWICZ MM, ZIRNHELD A L, Alard P. Gut microbiota, immunity, and disease: a complex relationship. www.frontiersin.org. Front Microbial 2011, 2:1-11.
  31. ZEYREK CD, ZEYREK F, SEVINC E, DEMIR E. Prevalence of asthma and allergic diseases in Sanliurfa, Turkey, and the relation to environmental and socioeconomic factors: is the hygiene hypothesis enough? J Investig Allergol ClinImmunol 2006; 16:290-295.
  32. SEISKARI T, KONDRASHOVA A, VISKARI H et al. The EPIVIR study group. Allergic sensitization and microbial load – a comparison between Finland and Russian Karelia. Clin Exp Immunol 2007; 148:47-52.
  33. CRITTENDEN, R.G. Prebiotics. In: TANNOCK, G.W., ed. Probiotics: a critical review. Norfolk: Horizon Scientific Press, 1999. p.141-156.
  34. SANDERS ME, Guarner F, Guerrant R, et al. (2013). An update on the use and investigation of probiotics in health and disease. Gut 62(5):787-796.
  35. WEICHSELBAUM E (2009). Probiotics and health: a review of the evidence. Nutrition Bulletin 34:340-373.
  36. GIBSON GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17:259-75.
  37. MANNING, T. S.; GIBSON, G. R. Microbial-gut interactions in health and disease. Prebiotics. Best Practice Research Clinical Gastroenterology, v. 18, n. 2, p. 287-298, 2004.
  38. GIBSON, G.R.; ROBERFROID, M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr., Bethesda, v.125, p.1401-1412, 1995.
  39. MAGNE, F. et al. Fecal microbial community in preterm infants. J. Pedriat. And Nutr., v.41, p.386-392, 2005.
  40. EISEMAN B, SILEN W, BASCOM GS, et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958 44:854–859.
  41. TURNBAUGH PJ, LEY RE, MAHOWALD MA, MAGRINI V, MARDIS ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027-31.;
  42. TURNBAUGH PJ, BÄCKHED F, FULTON L, GORDON JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3(4):213-23.
  43. FANDIÑO, J.; Segala, A. Indicações e contra-indicações para realização das operações bariátricas. Rev Bras de Psiq. Vol. 4. 2002. p. 68-72.;
  44. GIBSON, G.R.; FULLER, R. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. J. Nutr., Bethesda, v.130, p.391S-394S, 2000.
  45. BRANDT, K. G.; SAMPAIO, M. M. S. C.; MIUKI, C. J. Importância da microflora intestinal. Pediatria. v. 2, n. 28, p.117-127. 2006.

How to Cite

Ramirez, A. V. G. (2022). A importância da microbiota no organismo humano e sua relação com a obesidade. International Journal of Nutrology, 10(4), 153–160. https://doi.org/10.1055/s-0040-1705647